首页 | 本学科首页   官方微博 | 高级检索  
     


Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre,single-arm,phase 2 trial
Authors:Javier Martin-Broto  Silvia Stacchiotti  Antonio Lopez-Pousa  Andres Redondo  Daniel Bernabeu  Enrique de Alava  Paolo G Casali  Antoine Italiano  Antonio Gutierrez  David S Moura  Maria Peña-Chilet  Juan Diaz-Martin  Michele Biscuola  Miguel Taron  Paola Collini  Dominique Ranchere-Vince  Xavier Garcia del Muro  Giovanni Grignani  Josefina Cruz
Affiliation:1. Department of Medical Oncology, University Hospital Virgen del Rocío, Sevilla, Spain;2. Department of Pathology, University Hospital Virgen del Rocío, Sevilla, Spain;3. Clinical Bioinformatics Area, Fundación Progreso y Salud, University Hospital Virgen del Rocío, Sevilla, Spain;4. Institute of Biomedicine of Sevilla, Sevilla, Spain;5. Adult Mesenchymal and Rare Tumor Unit, Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;6. Soft Tissue and Bone Pathology, Histopathology and Pediatric Pathology Unit, Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;7. Department of Medical Oncology, Sant Pau Hospital, Barcelona, Spain;8. Department of Medical Oncology, University Hospital La Paz, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain;9. Musculoskeletal Imaging Section, University Hospital La Paz, Madrid, Spain;10. CIBERONC, Madrid, Spain;11. Department of Oncology, Institut Bergonié, Bordeaux, France;12. Department of Hematology, University Hospital Son Espases, Palma, Balearic Islands, Spain;13. Department of Pathology, Centre Léon Bérard, Université Claude Bernard Lyon, Lyon, France;14. Department of Medical Oncology, Centre Léon Bérard, Université Claude Bernard Lyon, Lyon, France;15. Catalan Institute of Oncology, Barcelona, Spain;p. Institut d''Investigació Biomédica de Bellvitge, University of Barcelona, Barcelona, Spain;q. Sarcoma Unit, Division of Medical Oncology, Candiolo Cancer Institute, FPO, IRCCS, Candiolo, Italy;r. Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France;s. Department of Medical Oncology, University Hospital Miguel Servet, Zaragoza, Spain;t. Chemotherapy Unit, Istituto Ortopedico Rizzoli, Bologna, Italy;u. Department of Medicine, University of Padua School of Medicine, Padua, Italy;v. Department of Medical Oncology, University Hospital of Canarias, Tenerife, Spain
Abstract:
Keywords:Correspondence to: Dr Javier Martin-Broto   LAB 215   Instituto de Biomedicina de Sevilla (IBIS)   Sevilla 41013   Spain
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号